Health & Fitness
Health and Fitness
Health and Fitness
Tue, February 24, 2009
Mon, February 23, 2009 Medical Nutrition USA Inc.: Coverage Initiated on Medical Nutrition USA Inc.
ENGLEWOOD, NJ--(Marketwire - February 23, 2009) - Medical Nutrition USA, Inc. (
The report outlines the company's growth and analyzes recent financial performance.
Highlights:
-- "Since being introduced to the institutional market less than six years ago, over 50 million servings of Pro-Stat® have been administered in over 5,000 US health care facilities." -- "The US population aged 65 and over is likely to double over the next two decades. MDNU is positioned to benefit from this massive demographic shift by leveraging its competitive position to further penetrate this population with new products while simultaneously expanding its target market to include institutional and, beginning in the second half of calendar 2009, retail users." -- "With a strong market position for the existing product offering, an attractive opportunity for expansion into retail, and the ability to leverage the existing distributor network into the Canadian institutional market, MDNU is well positioned for growth in revenue and profitability. Additionally, the Company's very strong balance sheet provides the capitalization to execute these expansion plans and to consider complementary acquisitions."
"This report provides insights into our company's performance and prospects that should be helpful to the investment community," Frank A. Newman, Medical Nutrition USA's Chairman, and Chief Executive Officer, said. "We are pleased that Murphy Analytics has initiated coverage and think that analyst coverage will help increase awareness of what our company has achieved and what we can accomplish in the months and years ahead."
The report can be accessed in the Investor Relations section of the Medical Nutrition web site: [ www.mdnu.com ].
About Medical Nutrition USA Inc.
Medical Nutrition USA develops and distributes products for the nutritionally at risk who are under medical supervision. Its products are used primarily in long-term care facilities, hospitals, dialysis clinics and bariatric clinics. The Company's product lines include Pro-Stat®, Fiber-Stat®, and UTI-Stat™, as well as private label products.
This press release contains forward-looking statements that are subject to certain risks and uncertainties. Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed. Risks and uncertainties that could cause or contribute to such material difference include, but are not limited to, general economic conditions, changes in customer demand, changes in trends in the nursing home, renal care, health food and bariatric surgery markets, changes in competitive pricing for products, and the impact of our competitors' new product introductions. Our future financial condition and results of operations, as well as any forward-looking statements are subject to change and inherent risk and uncertainties. Other important factors that may cause actual results to differ materially from those expressed in forward-looking statements is contained in the Medical Nutrition USA, Inc. Annual Report on Form 10-K for the year ended January 31, 2008 as filed with the Securities and Exchange Commission on April 29, 2008 and Form 10-Q for the quarter ended Oct. 31, 2008 filed on Dec. 15, 2008.
